TabletsTablets
Schedule H (Prescription Required)Antiemetics & GI MotilityCode: 1607

Drotaverine Hydrochloride Tablets 80 mg

Generic Formulation:Drotaverine Hydrochloride Tablets IP 80 mg
Pack Size:15's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹20.63
Brand Estimate*
₹160.39
Estimated Savings:₹139.76 (87% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Drotaverine Hydrochloride Tablets (40mg, 80mg) is an oral smooth muscle antispasmodic on the WHO Model List framework. As a selective PDE4 inhibitor, it relaxes visceral smooth muscle without anticholinergic activity, making it completely devoid of atropine-like adverse effects (no dry mouth, no urinary retention, no intraocular pressure elevation). Indicated for gastrointestinal spastic states (IBS, spastic colitis), biliary colic, cholecystitis, and ureteral colic.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1607.Report inaccuracy

Usage Guidelines

Take orally 40 to 80 mg three times daily with a glass of water, with or without food. Swallow whole.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Dizziness, headache, nausea, constipation, mild hypotension. Rare/Severe: Vertigo, palpitations, insomnia, and hypersensitivity reactions.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in severe hepatic, renal, or cardiac failure. Highly advantageous over anticholinergics in patients with prostatic hyperplasia or glaucoma.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.